SPO Global Inc. (SPOM)
SPO Global Inc. operates in the Software - Application industry of the Technology sector, headquartered in Orlando, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $69,292. On trailing twelve-month figures it carries a trailing P/E of -2.47, a net margin of 0.0%. Its beta of 0.68 implies it has historically moved less than the broad market.
Established in 2006 and headquartered in Jinan, China, Gerpang Healthcare Group operates as a bio-pharmaceutical enterprise. The company focuses on developing and marketing a diverse range of products, including genetically coated stents, vaccines for the Hepatitis B virus (HBV), monoclonal antibodies designed to detect male infertility, functional foods targeting cognitive disorders, and polypeptide-based probiotics.
SPO Global Inc. is most often compared with the following Technology names: